Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

INTRODUCTION: For patients with rheumatoid arthritis (RA) whose treatment with a tumour necrosis factor inhibitor (TNFi) is failing, several biological treatment options are available. Often, another TNFi or a biological with another mode of action is prescribed. The objective of this study was to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Manders, Sofie HM, Kievit, Wietske, Adang, Eddy, Brus, Herman L, Moens, Hein J Bernelot, Hartkamp, Andre, Hendriks, Lidy, Brouwer, Elisabeth, Visser, Henk, Vonkeman, Harald E, Hendrikx, Jos, Jansen, Tim L, Westhovens, Rene, van de Laar, Mart AFJ, van Riel, Piet LCM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489004/
https://www.ncbi.nlm.nih.gov/pubmed/25997746
http://dx.doi.org/10.1186/s13075-015-0630-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489004/
https://www.ncbi.nlm.nih.gov/pubmed/25997746
http://dx.doi.org/10.1186/s13075-015-0630-5

Ejemplares similares